Hillstream BioPharma, Inc. Profile Avatar - Palmy Investing

Hillstream BioPharma, Inc.

Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's produc…

Biotechnology
US, Bridgewater [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Hillstream BioPharma, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of HILS's Analysis
CIK: 1861657 CUSIP: 432705101 ISIN: US4327051011 LEI: - UEI: -
Secondary Listings
HILS has no secondary listings inside our databases.